Reductions in Symptomatology at a Residential Treatment Center for Substance Use Disorders

2018 ◽  
Vol 28 (10) ◽  
pp. 1173-1180
Author(s):  
Colin A. Ross ◽  
Melissa Caldwell Engle ◽  
Billie Baker
Author(s):  
Colin A. Ross ◽  
Colin A. Ross ◽  
Melissa Caldwell Engle ◽  
John Edmonson ◽  
Alexis Garcia

A replication study of treatment outcomes for patients at a residential treatment center for substance use disorders was conducted. A set of measures was completed on admission and discharge by 200 patients admitted to a residential treatment center for substance use disorders. Participants in the replication sample did not differ from those in the initial sample of 100 on age, gender or average length of stay, or on baseline scores on the Adverse Childhood Experiences Questionnaire or the Drug Abuse Screening Test. Nor did they differ on admission or discharge scores on the Dissociative Experiences Scale, the Beck Anxiety Inventory, the Beck Depression Inventory or the PTSD Checklist-Civilian Version. The results show that the marked symptom reductions seen in the initial study can be replicated. This is an important step in ongoing research on treatment outcomes for substance use disorders. The treatment provided was multimodal and trauma-informed and incorporated Twelve Step and other approaches.


2020 ◽  
Vol 3 (1) ◽  
pp. 223-229
Author(s):  
D M Makput

Patients with psychoactive substance use disorders (SUD) often have co- occurring medical and mental disorders. This occurs as a result of a number of factors, for instance, drug abuse may facilitate the full expression of a latent psychiatric disorder; mental disorder may lead to SUD (drugs used for self- medication; or both SUD and mental disorders are caused by the same underlying brain deficit such as genetic vulnerability, neurotransmitter abnormality, structural or functional abnormality, and so on. After obtaining ethical clearance, the case notes of all patients who were admitted in the Centre for Addiction Treatment and Research, (CATR) Vom, Plateau state throughout the first quarter of year 2019 were traced. A systematic random sample of every third consecutive patient was selected beginning with the first patient admitted and relevant data were collected and analyzed. A total of fourty- eight (48) in-patients were analyzed. Ninety -four percent (94%) of the patients were males, the mean age of 23.6 + 5 years with 46% being below 25 years of age. Fourty-six percent (46%) had cannabis as their primary drug followed by alcohol (32%) and opioids (28%). Only 1 % had a history of injecting drug use. Twenty-nine percent (29%) of the SUD patients had co-occurring depression, nine percent (8%) had anxiety disorder, and five percent (4%) had Post Traumatic Stress Disorder (PTSD) in addition to their substance use disorder. In line with sustainable development goals (SDG) goal 3.5 which seeks to “strengthen prevention and treatment of substance abuse including narcotics drug abuse and harmful use of alcohol”; identifying co-occurring mental disorders among patients with substance use disorders is one way of moving closer towards achieving this SDG.


Sign in / Sign up

Export Citation Format

Share Document